STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug
STAT
MARCH 6, 2023
“I’m slowly running out of options,” said Young, 62, who in November began receiving a five-month series of shots at a clinic near her San Francisco home; the vaccine is designed to teach her immune cells to recognize and combat tumors. And a little guilty.
95 
Let's personalize your content